The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Authors
Keywords
-
Journal
Biochemia Medica
Volume 33, Issue 3, Pages 266-278
Publisher
Croatian Society for Medical Biochemistry and Laboratory Medicine
Online
2023-10-11
DOI
10.11613/bm.2023.030504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endogenous production of ω-3 polyunsaturated fatty acids mitigates cisplatin-induced myelosuppression by regulating NRF2-MDM2-p53 signaling pathway
- (2023) Qihua Xu et al. FREE RADICAL BIOLOGY AND MEDICINE
- NFR2/ABC transporter axis in drug resistance of breast cancer cells
- (2023) Zinat Sargazi et al. MOLECULAR BIOLOGY REPORTS
- Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways
- (2022) Md Afjalus Siraj et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy
- (2022) Zhila Khodabandeh et al. Breast Cancer
- Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment
- (2022) Hitesh Kumar et al. Frontiers in Pharmacology
- Nrf2 Modulates the Hybrid Epithelial/Mesenchymal Phenotype and Notch Signaling During Collective Cancer Migration
- (2022) Samuel A. Vilchez Mercedes et al. Frontiers in Molecular Biosciences
- Nrf2 Modulation in Breast Cancer
- (2022) Somayyeh Ghareghomi et al. Biomedicines
- The measurement of NRF2 and TP53 in blood expects radiotherapeutic sensitivity in patients with esophageal cancer
- (2022) Huiqin Xu et al. MOLECULAR AND CELLULAR PROBES
- Mangiferin Inhibits Apoptosis in Doxorubicin-Induced Vascular Endothelial Cells via the Nrf2 Signaling Pathway
- (2021) Mohammad Bani Ismail et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism
- (2021) Moon-Young Song et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair
- (2021) Shenghui Qin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Understanding breast cancer as a global health concern
- (2021) Louise Wilkinson et al. BRITISH JOURNAL OF RADIOLOGY
- p53 signaling in cancer progression and therapy
- (2021) Hany E. Marei et al. Cancer Cell International
- NRF2 as a Therapeutic Target in Neurodegenerative Diseases
- (2020) Mikah S. Brandes et al. ASN Neuro
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Antiproliferative Activity of Ursolic Acid in MDA-MB-231 Human Breast Cancer Cells through Nrf2 Pathway Regulation
- (2020) Xi Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Determination of expression profile of p53 gene in different grades of breast cancer tissues by real time PCR
- (2020) Haleema Sadia et al. African Health Sciences
- Dysregulation of body antioxidant content is related to initiation and progression of Parkinson’s disease
- (2020) Abolfazl Fattah et al. NEUROSCIENCE LETTERS
- Sulforaphane induces colorectal cancer cell proliferation through Nrf2 activation in a p53-dependent manner
- (2020) Yunjeong Gwon et al. Applied Biological Chemistry
- Oxidative Stress and Cancer
- (2019) James E. Klaunig CURRENT PHARMACEUTICAL DESIGN
- Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
- (2019) Jinmei Jin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis
- (2019) Micaela Almeida et al. BREAST CANCER RESEARCH AND TREATMENT
- Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA
- (2019) Yuan Huang et al. CELL CYCLE
- The potentially protective role of ATP-binding cassette transporters in preeclampsia via Nrf2
- (2019) Lu Yu et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic strategies
- (2018) Raman Preet Kaur et al. CURRENT PHARMACEUTICAL DESIGN
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Protective role of p53 in acetaminophen hepatotoxicity
- (2017) Yazhen Huo et al. FREE RADICAL BIOLOGY AND MEDICINE
- p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes
- (2017) Kyrie Pappas et al. MOLECULAR CANCER RESEARCH
- NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
- (2017) Delin Chen et al. MOLECULAR CELL
- Overexpression of NRF2 is correlated with prognoses of patients with malignancies: A meta-analysis
- (2017) Yangyang Guo et al. Thoracic Cancer
- Dynamics of p53: A Master Decider of Cell Fate
- (2017) Qingyin Luo et al. Genes
- Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
- (2017) Z Fan et al. Oncogenesis
- The Role of Oxidative Stress Modulators in Breast Cancer
- (2017) Hande Gurer-Orhan et al. CURRENT MEDICINAL CHEMISTRY
- NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
- (2016) Iok In Christine Chio et al. CELL
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231
- (2016) Chao Meng et al. ONCOLOGY REPORTS
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
- (2016) Youngtae Jeong et al. Cancer Discovery
- Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
- (2016) Jhih-Pu Syu et al. Oncotarget
- Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
- (2016) Raie T. Bekele et al. Scientific Reports
- Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma
- (2015) Mingxin Zhang et al. BMC CANCER
- Crosstalk between Nrf2 and Notch signaling
- (2015) Nobunao Wakabayashi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
- (2015) In-geun Ryoo et al. Oncotarget
- Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
- (2015) Min-Che Tung et al. Oncotarget
- Mutant p53: One, No One, and One Hundred Thousand
- (2015) Dawid Walerych et al. Frontiers in Oncology
- Regulation of Mutant p53 Protein Expression
- (2015) Reshma Vijayakumaran et al. Frontiers in Oncology
- NRF2 and p53: Januses in cancer?
- (2015) Barak Rotblat et al. Oncotarget
- The PTEN/NRF2 Axis Promotes Human Carcinogenesis
- (2014) Ana I. Rojo et al. ANTIOXIDANTS & REDOX SIGNALING
- Oleuropein Induces Apoptosis Via the p53 Pathway in Breast Cancer Cells
- (2014) Zeinab Korany Hassan et al. Asian Pacific Journal of Cancer Prevention
- Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
- (2014) S. Tao et al. CANCER RESEARCH
- TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
- (2014) L. Silwal-Pandit et al. CLINICAL CANCER RESEARCH
- Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells
- (2014) Samik Chakraborty et al. FEBS LETTERS
- Propofol Attenuates Lipopolysaccharide-Induced Reactive Oxygen Species Production Through Activation of Nrf2/GSH and Suppression of NADPH Oxidase in Human Alveolar Epithelial Cells
- (2014) Hung-Te Hsu et al. INFLAMMATION
- Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status
- (2014) Pavla Bouchalova et al. JOURNAL OF PATHOLOGY
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers
- (2013) Keiko Taguchi et al. MOLECULAR AND CELLULAR BIOLOGY
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
- (2013) Matthew J. Ellis et al. Cancer Discovery
- Does Nrf2 Contribute to p53-Mediated Control of Cell Survival and Death?
- (2012) Weimin Chen et al. ANTIOXIDANTS & REDOX SIGNALING
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent
- (2012) Sharifah S. Syed Alwi et al. CELL STRESS & CHAPERONES
- Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response
- (2012) Yan Zhong et al. MOLECULAR CARCINOGENESIS
- High frequency of complex TP53 mutations in CNS metastases from breast cancer
- (2011) C Lo Nigro et al. BRITISH JOURNAL OF CANCER
- Histological, molecular and functional subtypes of breast cancers
- (2011) Gautam K. Malhotra et al. CANCER BIOLOGY & THERAPY
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Role of p53 in Neurodegenerative Diseases
- (2011) J. Robert Chang et al. Neurodegenerative Diseases
- Development of Defective and Persistent Sendai Virus Vector
- (2010) Ken Nishimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ubiquitin-independent p53 proteasomal degradation
- (2009) P Tsvetkov et al. CELL DEATH AND DIFFERENTIATION
- p53 isoform 113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
- (2009) J. Chen et al. GENES & DEVELOPMENT
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
- (2009) Truyen Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy
- (2009) M. Loignon et al. MOLECULAR CANCER THERAPEUTICS
- Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
- (2009) Weimin Chen et al. MOLECULAR CELL
- p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
- (2009) Kaori Fujita et al. NATURE CELL BIOLOGY
- Dual roles of Nrf2 in cancer
- (2008) A LAU et al. PHARMACOLOGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now